RemSleep Holdings Finalizes Nationwide Sales Rep Contracts for Deltawave™ CPAP Mask System Launch
Reuters
Oct 01
RemSleep Holdings Finalizes Nationwide Sales Rep Contracts for Deltawave™ CPAP Mask System Launch
RemSleep Holdings Inc., the developer of the FDA-cleared Deltawave™ CPAP mask system, has announced the finalization of contracts with independent sales representatives covering the entire United States. The company reported that fulfillment inventory for the Deltawave™ system has arrived and is ready to meet the needs of durable medical equipment providers and customers. RemSleep is also developing instructional materials, including a video and a brochure, to support the sales team. The company is currently evaluating an enterprise resource planning system to manage inventory, accounting, customer relations, and business analytics as part of its ongoing efforts to streamline operations and support product launch activities.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. RemSleep Holdings Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 1080557) on October 01, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.